KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Charles River Laboratories International (CRL) Other Gross PP&E Adjustments (2016 - 2025)

Charles River Laboratories International has reported Other Gross PP&E Adjustments over the past 16 years, most recently at $3.2 billion for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 19.75% year-over-year to $3.2 billion; the TTM value through Dec 2025 reached $3.2 billion, up 19.75%, while the annual FY2025 figure was $3.2 billion, 19.75% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $3.2 billion at Charles River Laboratories International, up from $2.7 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $3.2 billion in Q4 2025 and troughed at -$408.5 million in Q2 2023.
  • A 5-year average of $1.3 billion and a median of $2.3 billion in 2021 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 1106.04% in 2022 and later surged 824.26% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $2.4 billion in 2021, then dropped by 5.48% to $2.2 billion in 2022, then soared by 31.79% to $2.9 billion in 2023, then fell by 10.18% to $2.6 billion in 2024, then rose by 19.75% to $3.2 billion in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for CRL at $3.2 billion in Q4 2025, $2.7 billion in Q3 2025, and $2.7 billion in Q2 2025.